LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

Search

Fulgent Genetics Inc

Abierto

SectorSalud

21.38 1.18

Resumen

Variación precio

24h

Actual

Mínimo

20.65

Máximo

21.41

Métricas clave

By Trading Economics

Ingresos

-5.7M

-12M

Ventas

-2.8M

73M

BPA

0.04

Margen de beneficio

-16.197

Empleados

1,313

EBITDA

-2M

-12M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+15.27% upside

Dividendos

By Dow Jones

Próximas Ganancias

1 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

57M

629M

Apertura anterior

20.2

Cierre anterior

21.38

Noticias sobre sentimiento de mercado

By Acuity

78%

22%

357 / 380 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

Fulgent Genetics Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

5 jun 2025, 20:45 UTC

Ganancias

Broadcom 2Q Sales Climb on Booming AI Demand

5 jun 2025, 23:45 UTC

Charlas de Mercado

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

5 jun 2025, 23:44 UTC

Charlas de Mercado

Gold Edges Higher on Weak U.S. Data -- Market Talk

5 jun 2025, 23:30 UTC

Charlas de Mercado

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

5 jun 2025, 21:32 UTC

Ganancias

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 jun 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

5 jun 2025, 20:45 UTC

Ganancias

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 jun 2025, 20:24 UTC

Ganancias

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 jun 2025, 20:15 UTC

Ganancias

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

5 jun 2025, 20:15 UTC

Ganancias

Broadcom 2Q Rev $15B >AVGO

5 jun 2025, 20:15 UTC

Ganancias

Broadcom 2Q Net $4.97B >AVGO

5 jun 2025, 20:15 UTC

Ganancias

Broadcom 2Q Adj EPS $1.58 >AVGO

5 jun 2025, 20:15 UTC

Ganancias

Broadcom 2Q EPS $1.03 >AVGO

5 jun 2025, 20:15 UTC

Ganancias

Broadcom Sees 3Q Rev $15.8B >AVGO

5 jun 2025, 20:11 UTC

Adquisiciones, fusiones, absorciones

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

5 jun 2025, 20:11 UTC

Adquisiciones, fusiones, absorciones

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

5 jun 2025, 20:11 UTC

Adquisiciones, fusiones, absorciones

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

5 jun 2025, 19:22 UTC

Charlas de Mercado

Oil Futures Resume Upward Moves -- Market Talk

5 jun 2025, 19:00 UTC

Charlas de Mercado

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

5 jun 2025, 18:32 UTC

Charlas de Mercado

Gold Slips After Trump-Xi Call -- Market Talk

5 jun 2025, 18:26 UTC

Ganancias

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

5 jun 2025, 18:06 UTC

Charlas de Mercado

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

5 jun 2025, 16:30 UTC

Adquisiciones, fusiones, absorciones

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

5 jun 2025, 16:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

5 jun 2025, 16:18 UTC

Charlas de Mercado

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

5 jun 2025, 16:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

5 jun 2025, 16:12 UTC

Charlas de Mercado

Global Energy Roundup: Market Talk

5 jun 2025, 16:12 UTC

Charlas de Mercado

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

5 jun 2025, 16:03 UTC

Charlas de Mercado

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

5 jun 2025, 15:49 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

Comparación entre iguales

Cambio de precio

Fulgent Genetics Inc Esperado

Precio Objetivo

By TipRanks

15.27% repunte

Estimación a 12 meses

Media 24 USD  15.27%

Máximo 25 USD

Mínimo 23 USD

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Fulgent Genetics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

2 ratings

1

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

17.32 / 19.04Soporte y Resistencia

Corto Plazo

Bearish Evidence

Medio plazo

Strong Bullish Evidence

Largo Plazo

Neutral Evidence

Sentimiento

By Acuity

357 / 380 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura bajista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Fulgent Genetics Inc

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.